StockNews.com Downgrades Edap Tms (NASDAQ:EDAP) to Sell

Edap Tms (NASDAQ:EDAP) was downgraded by investment analysts at StockNews.com from a “hold” rating to a “sell” rating in a research note issued on Friday.

Separately, HC Wainwright raised their price target on shares of Edap Tms from $16.00 to $19.00 and gave the stock a “buy” rating in a research note on Monday, April 1st.

Edap Tms Trading Up 1.8 %

EDAP stock opened at $7.26 on Friday. The company has a market capitalization of $269.35 million, a PE ratio of -11.52 and a beta of 0.74. Edap Tms has a 12 month low of $3.60 and a 12 month high of $12.23. The firm’s 50-day moving average is $7.12 and its 200 day moving average is $6.27. The company has a debt-to-equity ratio of 0.04, a current ratio of 2.84 and a quick ratio of 2.30.

Edap Tms (NASDAQ:EDAP) last posted its quarterly earnings results on Wednesday, March 27th. The medical equipment provider reported ($0.15) EPS for the quarter, missing the consensus estimate of ($0.02) by ($0.13). The company had revenue of $21.27 million during the quarter, compared to analysts’ expectations of $21.30 million. Edap Tms had a negative return on equity of 34.33% and a negative net margin of 35.03%. On average, research analysts anticipate that Edap Tms will post -0.31 EPS for the current year.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Cetera Advisor Networks LLC grew its holdings in Edap Tms by 0.9% during the 4th quarter. Cetera Advisor Networks LLC now owns 111,162 shares of the medical equipment provider’s stock worth $1,185,000 after acquiring an additional 944 shares in the last quarter. BlackRock Inc. boosted its holdings in shares of Edap Tms by 27.3% in the 1st quarter. BlackRock Inc. now owns 13,527 shares of the medical equipment provider’s stock valued at $150,000 after buying an additional 2,898 shares in the last quarter. Envestnet Asset Management Inc. boosted its holdings in shares of Edap Tms by 24.6% in the 3rd quarter. Envestnet Asset Management Inc. now owns 14,736 shares of the medical equipment provider’s stock valued at $122,000 after buying an additional 2,911 shares in the last quarter. Commonwealth Equity Services LLC boosted its holdings in shares of Edap Tms by 5.3% in the 1st quarter. Commonwealth Equity Services LLC now owns 65,135 shares of the medical equipment provider’s stock valued at $721,000 after buying an additional 3,250 shares in the last quarter. Finally, Royal Bank of Canada boosted its holdings in shares of Edap Tms by 22.5% in the 2nd quarter. Royal Bank of Canada now owns 18,375 shares of the medical equipment provider’s stock valued at $169,000 after buying an additional 3,375 shares in the last quarter. 62.74% of the stock is currently owned by institutional investors.

About Edap Tms

EDAP TMS SA, together with its subsidiaries, develops, produces, markets, distributes, and maintains a portfolio of minimally invasive medical devices for the treatment of urological diseases in Asia, France, the United States, and internationally. The company operates through High Intensity Focused Ultrasound (HIFU), Extracorporeal ShockWave Lithotripsy (ESWL), and Distribution Services (DIST) segments.